- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0011860

About Vision Drugs Private Limited
Data last updated:
Vision Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U99999TG2005PTC048204. Its GSTIN is 36AACCV1895P1ZK (Telangana). The company holds 5 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹15.84 Cr. It is led by directors including Ram Mohan Polsani Rao (Managing Director) and Prasanth Nandigala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹159.84 Cr, a growth of 12% compared to the previous year. Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The company has about 325 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vision Drugs. As per MCA filings, the company has open charges of ₹107.94 Cr and satisfied charges of ₹9.14 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 2 cases are pending. The company has 6 deals on record (6 secondary share transfers); the latest was in September 2017. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Vasista Life Sciences Private Limited with revenue of ₹162.88 Cr.
Vision Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0011860). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website visiondrugs.co.in.
Company details
CIN history
Vision Drugs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U99999TG2005PTC048204, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999TG2005PTC048204 | Current |
| U99999AP9999PLC048204 | Previous |
| U99999TG9999PLC048204 | Previous |
Recognitions & Rankings of Vision Drugs
Contact details
Vision Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is visiondrugs.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 67 2nd Floor, Chitiprolu Arcade Hi – Tech City, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Vision Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vision Drugs operates one associated brand: Vision Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API and intermediates manufacturing in the pharmaceutical sector. | visiondrugs.co.in |
Financials of Vision Drugs Private Limited
FY 2025 filings availableVision Drugs Private Limited reported revenue of ₹159.84 Cr (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 12% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹159.84 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vision Drugs Private Limited, buy the company report.
Board of directors of Vision Drugs Private Limited
Vision Drugs has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasanth Nandigala Also directs: Pokarna Limited, Virchow Agrochemicals Private Limited, Pokarna Engineered Stone Limited and 5 more | Additional Director | 22 Dec 2025 | 0 Years 10 Months | Current |
| Srinivasa Reddy Battula Also directs: Dr. Battula's Life Sciences Private Limited | Additional Director | 22 Dec 2025 | 0 Years 10 Months | Current |
| Mundla Maha Vishnu Also directs: Ceph Lifesciences Private Limited, Virchow Petrochemical Private Limited, Andhra Organics Limited and 5 more | Additional Director | 22 Dec 2025 | 0 Years 10 Months | Current |
| Ram Mohan Polsani Rao | Managing Director | 13 Aug 2009 | 17 Years 2 Months | Current |
Peer comparison
Vision Drugs Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasista Life Sciences Private Limited | ₹162.88 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Syntho Chirals Private Limited | ₹162.38 Cr (FY 2024) | 23.0% | Hyderabad, Telangana, India | |||
| Vivin Drugs & Pharmaceuticals Private Limited | ₹161.52 Cr (FY 2023) | -25.0% | Hyderabad, Telangana, India | |||
| Valentis Laboratories Private Limited | ₹160.96 Cr (FY 2025) | 135.0% | Sangareddy, Telangana, India | |||
| Everest Organics Limited | ₹160.17 Cr (FY 2025) | -19.0% | Medak, Telangana, India | |||
| Vision Drugs Private Limitedthis company | ₹159.84 Cr (FY 2024) | 12.0% | 325 | Hyderabad, Telangana, India | ||
| Infinium Pharmachem Limited | ₹157.83 Cr (FY 2025) | 15.0% | Sojitra, Gujarat, India | |||
| Gujarat Themis Biosyn Ltd | ₹153.23 Cr (FY 2025) | -12.0% | Valsad, Gujarat, India | |||
| Allchem Lifescience Limited | ₹152.78 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Rampex Labs Private Limited | ₹152.68 Cr (FY 2025) | 16.0% | Bollaram Villege, Telangana, India | |||
| SPC Life Sciences Limited | ₹151.89 Cr (FY 2025) | -3.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Vision Drugs Private Limited, buy the company report.
Auditor
Vision Drugs Private Limited is audited by I V H Rao & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| I V H Rao & Co | FY 2024 | 018251S |
Shareholding
The shareholding of Vision Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vision Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Oct 2024 | 100994103 | Others | ₹2 Cr | Open | |
| 20 Aug 2024 | 100966833 | Others | ₹2.25 Cr | Open | |
| 04 Jun 2024 | 100953080 | Hdfc Bank Limited | ₹76 Lakh | Open | |
| 17 Nov 2021 | 100509026 | Axis Bank Limited | ₹1.25 Cr | Open | |
| 16 Sep 2021 | 100482226 | Hdfc Bank Limited | ₹59.67 Lakh | Open |
To see the full charge records of Vision Drugs Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Vision Drugs Private Limited has 6 deals on record (6 secondary share transfers); the latest was in September 2017.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2014 | Secondary share transfer | Undisclosed | Buyer: Dhanvika Solvent Solutions Private Limited Seller: 4 individuals |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: PHRM Chemicals Private Limited |
| Sep 2008 | Secondary share transfer | Undisclosed | Buyer: PHRM Chemicals Private Limited , 2 individuals Seller: 4 individuals |
To see the full deal history of Vision Drugs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vision Drugs Private Limited has 7 court cases on record: 3 filed by Vision Drugs, 4 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 4 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Messers Deep Pharm Chem Pvt Ltd Through Its Authorized Representativenavin Amarshi Harsora | Disposed |
| District court, Bharuch, Gujarat | Criminal complaint | Filed against the company by Ramesh Amarshi Hansora Authorized Representative of M/S Deep Pharm Chem Pvt. Ltd. | Disposed |
| District court, Bharuch, Gujarat | Court case (CR EN) | Filed against the company by Ramesh Amarshi Hansora Authorized Representative of M/S Deep Pharm Chem Pvt. Ltd. | Disposed |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. SRS Pharma Tech Rep by Vijay Kailash Rawal and 1 other | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Kothari Pharma Industries, Rep by Amit Babulal Kothari and 1 other | Pending |
To see the full case history of Vision Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vision Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vision Drugs Private Limited has a workforce of 325 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Vision Drugs has 5 GST registrations: 3 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCV1895P1ZK | Telangana | Active | 01 Jul 2017 |
| 36AACCV1895P2ZJ | Telangana | Active | 14 Mar 2025 |
| 37AACCV1895P3ZG | Andhra Pradesh | Active | 14 Dec 2017 |
To see the full GST registrations and return filing status of Vision Drugs Private Limited, buy the company report.
Recent activity
Vision Drugs Private Limited has 15 board changes on record since 2009: 4 appointments and 11 cessations. The latest: Haritha Polsani ceased to be Director on 22 Dec 2025.
26 earlier events are in the company report.
Frequently asked questions
Vision Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 November 2005 (21+ years old) and is registered under CIN U99999TG2005PTC048204.
Vision Drugs has 4 current directors:
- Ram Mohan Polsani Rao - Managing Director
- Prasanth Nandigala - Additional Director
- Srinivasa Reddy Battula - Additional Director
- Mundla Maha Vishnu - Additional Director
The latest financial statements of Vision Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vision Drugs is 36AACCV1895P1ZK, registered in Telangana. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 36AACCV1895P2ZJ (Telangana), 37AACCV1895P3ZG (Andhra Pradesh).
The CIN (Corporate Identification Number) of Vision Drugs is U99999TG2005PTC048204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vision Drugs has 7 court cases on record: 3 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Vision Drugs was incorporated on 28 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vision Drugs has 6 deals on record (6 secondary share transfers); the latest was in September 2017.
The peers of Vision Drugs by revenue are Vasista Life Sciences Private Limited, Syntho Chirals Private Limited, Vivin Drugs & Pharmaceuticals Private Limited, Valentis Laboratories Private Limited, Everest Organics Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Haritha Polsani ceased to be Director on 22 Dec 2025. Mundla Maha Vishnu was appointed as Additional Director on 22 Dec 2025. Prasanth Nandigala was appointed as Additional Director on 22 Dec 2025. Vision Drugs has 15 board changes on record in total.
Yes, Vision Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0011860).

